BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,788,228 | -1.9% | 4,481,839 | +30.2% | 0.54% | -5.4% |
| Q2 2023 | $109,887,797 | +4.6% | 3,441,522 | +0.3% | 0.57% | -1.7% |
| Q1 2023 | $105,085,421 | -21.0% | 3,431,921 | +0.9% | 0.58% | -26.8% |
| Q4 2022 | $132,970,910 | -23.1% | 3,399,921 | -6.4% | 0.79% | -17.0% |
| Q3 2022 | $172,994,000 | +28.7% | 3,631,271 | +4.6% | 0.96% | +30.6% |
| Q2 2022 | $134,412,000 | -9.6% | 3,472,271 | +33.8% | 0.73% | +2.1% |
| Q1 2022 | $148,658,000 | -17.6% | 2,594,387 | +14.5% | 0.72% | -20.4% |
| Q4 2021 | $180,501,000 | +20.8% | 2,265,045 | +31.9% | 0.90% | +29.2% |
| Q3 2021 | $149,448,000 | -22.6% | 1,717,590 | +14.5% | 0.70% | -11.4% |
| Q2 2021 | $193,065,000 | +307.1% | 1,500,000 | +153.2% | 0.79% | +233.9% |
| Q1 2021 | $47,422,000 | +1448.2% | 592,481 | +248.2% | 0.24% | +807.7% |
| Q1 2020 | $3,063,000 | – | 170,164 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |